四肢肉瘤新辅助图像引导螺旋调强放射治疗的单中心经验
2010至2014年共41例四肢软组织肉瘤患者接受螺旋调强图像引导新辅助放疗,纵向2.5 cm、轴向1.0 cm缩减安全边界,40例完成50 Gy/2 Gy分次。中位随访38.5个月,2年总生存78.2%、局部无进展生存85.2%、全身无进展生存54.5%,主要伤口并发症36.8%,6例局部复发中2例为近端边缘漏照。
要点
- 缩减边界的新辅助IGRT-IMRT总体耐受性好,毒性低。
- 2年总生存78.2%、局部PFS 85.2%、全身PFS 54.5%。
- 6例局部复发中2例为纵向近端边缘漏照,提示缩减纵向边界需谨慎。
核心结论
- 调强放射治疗-图像引导放射治疗(IMRT-IGRT)为四肢软组织肉瘤提供新辅助治疗并缩减安全边界,毒性低。
- 伤口并发症率与既往报道频率相当。
- 2例边缘漏照提示缩减纵向安全边界需谨慎。
研究设计与样本
- 2010至2014年单中心41例四肢软组织肉瘤患者接受螺旋调强放射治疗(IMRT)断层治疗机图像引导放射治疗(IGRT)。
- 肿瘤位于上肢6例(15%)、下肢35例(85%)。
- 基于MRI定义的大体肿瘤体积(含瘤周水肿)外扩至临床靶体积:纵向2.5 cm、轴向1.0 cm,再外扩5 mm为计划靶体积。
- 40例成功完成50 Gy/2 Gy分次全量放疗;2例因全身进展接受化疗而非手术。
- 38例接受全量放疗并后续切除者纳入结局分析。
主要发现
- 中位随访38.5个月,2年累计总生存(OS)78.2%、局部无进展生存(PFS)85.2%、全身PFS 54.5%。
- 6例局部复发中2例为近端边缘漏照。
- 84%患者达到阴性切除边缘。
- 主要伤口并发症率为36.8%,与既往IMRT研究相当。
- 放疗总体可耐受,毒性率低。
临床怎么用
- IMRT-IGRT可用于四肢软组织肉瘤新辅助治疗并缩减安全边界,毒性低。
- 缩减纵向安全边界时需注意2例近端边缘漏照的教训。
- 主要伤口并发症率36.8%与既往IMRT研究相当。
局限性
- 2例边缘漏照提示缩减纵向安全边界需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Advanced radiotherapy (RT) techniques allow normal tissue to be spared in patients with extremity soft tissue sarcoma (STS). This work aims to evaluate toxicity and outcome after neoadjuvant image-guided radiotherapy (IGRT) as helical intensity modulated radiotherapy (IMRT) with reduced margins based on MRI-based target definition in patients with STS. METHODS: Between 2010 to 2014, 41 patients with extremity STS were treated with IGRT delivered as helical IMRT on a tomotherapy machine. The tumor site was in the upper extremity in 6 patients (15%) and lower extremity in 35 patients (85%). Reduced margins of 2.5 cm in longitudinal direction and 1.0 cm in axial direction were used to expand the MRI-defined gross tumor volume, including peritumoral edema, to the clinical target volume. An additional margin of 5 mm was added to receive the planning target volume. The full total dose of 50 Gy in 2 Gy fractions was sucessfully applied in 40 patients. Two patients received chemotherapy instead of surgery due to systemic progression. All patients were included into a strict follow-up program and were seen interdisciplinarily by the Departments of Orthopaedic Surgery and Radiation Oncology. RESULTS: Thirty eight patients that received total RT total dose and subsequent resection were analyzed for outcome. After a median follow-up of 38.5 months cumulative OS, local PFS and systemic PFS at 2 years were determined at 78.2, 85.2 and 54.5%, respectively. Two of 6 local recurrences were proximal marginal misses. Negative resection margins were achieved in 84% of patients. The rate of major wound complications was comparable to previous IMRT studies with 36.8%. RT was overall tolerable with low toxicity rates. CONCLUSIONS: IMRT-IGRT offers neoadjuvant treatment for extremity STS with reduced safety margins and thus low toxicity rates. Wound complication rates were comparable to previously reported frequencies. Two reported marginal misses suggest a word of caution for reduction of longitudinal safety margins.
引用
- Peeken JC, Knie C, Kessel KA, et al. Neoadjuvant image-guided helical intensity modulated radiotherapy of extremity sarcomas - a single center experience. Radiat Oncol. 2019. PMID: 30626408. doi:10.1186/s13014-019-1207-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。